multi omics data (Foundation Medicine Inc)
Foundation Medicine Inc is a verified supplier 
Foundation Medicine Inc manufactures this product 
99
Structured Review
Foundation Medicine Inc
multi omics data
Multi Omics Data, supplied by Foundation Medicine Inc, used in various techniques. Bioz Stars score: 99/100, based on 2296 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multi-omics+data/FoundationOne+CDx/pm42034603-270-30-37
Average 99 stars, based on 2296 article reviews
Multi Omics Data, supplied by Foundation Medicine Inc, used in various techniques. Bioz Stars score: 99/100, based on 2296 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multi-omics+data/FoundationOne+CDx/pm42034603-270-30-37
Average 99 stars, based on 2296 article reviews
multi omics data - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
Analysis:Article Title: Pathological Complete Response after Conversion Surgery for Distal Cholangiocarcinoma with High Tumor Mutational Burden and Para-Aortic Lymph Node Metastasis: A Case Report Article Snippet: hich was within the normal range ( Fig. 3 ). The tumor resection was deemed ineligible, and GCD therapy was initiated as the first-line treatment. Comprehensive CGP analysis of the tissue sample using Biomarker Discovery:Article Title: Pathological Complete Response after Conversion Surgery for Distal Cholangiocarcinoma with High Tumor Mutational Burden and Para-Aortic Lymph Node Metastasis: A Case Report Article Snippet: hich was within the normal range ( Fig. 3 ). The tumor resection was deemed ineligible, and GCD therapy was initiated as the first-line treatment. Comprehensive CGP analysis of the tissue sample using Generated:Article Title: Pathological Complete Response after Conversion Surgery for Distal Cholangiocarcinoma with High Tumor Mutational Burden and Para-Aortic Lymph Node Metastasis: A Case Report Article Snippet: hich was within the normal range ( Fig. 3 ). The tumor resection was deemed ineligible, and GCD therapy was initiated as the first-line treatment. Comprehensive CGP analysis of the tissue sample using Sequencing:Article Title: Pathological Complete Response after Conversion Surgery for Distal Cholangiocarcinoma with High Tumor Mutational Burden and Para-Aortic Lymph Node Metastasis: A Case Report Article Snippet: hich was within the normal range ( Fig. 3 ). The tumor resection was deemed ineligible, and GCD therapy was initiated as the first-line treatment. Comprehensive CGP analysis of the tissue sample using Variant Assay:Article Title: Pathological Complete Response after Conversion Surgery for Distal Cholangiocarcinoma with High Tumor Mutational Burden and Para-Aortic Lymph Node Metastasis: A Case Report Article Snippet: hich was within the normal range ( Fig. 3 ). The tumor resection was deemed ineligible, and GCD therapy was initiated as the first-line treatment. Comprehensive CGP analysis of the tissue sample using Tissue Samples:Article Title: Pathological Complete Response after Conversion Surgery for Distal Cholangiocarcinoma with High Tumor Mutational Burden and Para-Aortic Lymph Node Metastasis: A Case Report Article Snippet: hich was within the normal range ( Fig. 3 ). The tumor resection was deemed ineligible, and GCD therapy was initiated as the first-line treatment. Comprehensive CGP analysis of the tissue sample using Oligomer Restriction:Article Title: Pathological Complete Response after Conversion Surgery for Distal Cholangiocarcinoma with High Tumor Mutational Burden and Para-Aortic Lymph Node Metastasis: A Case Report Article Snippet: hich was within the normal range ( Fig. 3 ). The tumor resection was deemed ineligible, and GCD therapy was initiated as the first-line treatment. Comprehensive CGP analysis of the tissue sample using Tissue:Article Title: Pathological Complete Response after Conversion Surgery for Distal Cholangiocarcinoma with High Tumor Mutational Burden and Para-Aortic Lymph Node Metastasis: A Case Report Article Snippet: hich was within the normal range ( Fig. 3 ). The tumor resection was deemed ineligible, and GCD therapy was initiated as the first-line treatment. Comprehensive CGP analysis of the tissue sample using Next-Generation Sequencing:Article Title: Pathological Complete Response after Conversion Surgery for Distal Cholangiocarcinoma with High Tumor Mutational Burden and Para-Aortic Lymph Node Metastasis: A Case Report Article Snippet: hich was within the normal range ( Fig. 3 ). The tumor resection was deemed ineligible, and GCD therapy was initiated as the first-line treatment. Comprehensive CGP analysis of the tissue sample using Polymerase Chain Reaction:Article Title: Pathological Complete Response after Conversion Surgery for Distal Cholangiocarcinoma with High Tumor Mutational Burden and Para-Aortic Lymph Node Metastasis: A Case Report Article Snippet: hich was within the normal range ( Fig. 3 ). The tumor resection was deemed ineligible, and GCD therapy was initiated as the first-line treatment. Comprehensive CGP analysis of the tissue sample using Multiplex PCR:Article Title: Pathological Complete Response after Conversion Surgery for Distal Cholangiocarcinoma with High Tumor Mutational Burden and Para-Aortic Lymph Node Metastasis: A Case Report Article Snippet: hich was within the normal range ( Fig. 3 ). The tumor resection was deemed ineligible, and GCD therapy was initiated as the first-line treatment. Comprehensive CGP analysis of the tissue sample using Multiplex Assay:Article Title: Pathological Complete Response after Conversion Surgery for Distal Cholangiocarcinoma with High Tumor Mutational Burden and Para-Aortic Lymph Node Metastasis: A Case Report Article Snippet: hich was within the normal range ( Fig. 3 ). The tumor resection was deemed ineligible, and GCD therapy was initiated as the first-line treatment. Comprehensive CGP analysis of the tissue sample using Positron Emission Tomography:Article Title: Pathological Complete Response after Conversion Surgery for Distal Cholangiocarcinoma with High Tumor Mutational Burden and Para-Aortic Lymph Node Metastasis: A Case Report Article Snippet: hich was within the normal range ( Fig. 3 ). The tumor resection was deemed ineligible, and GCD therapy was initiated as the first-line treatment. Comprehensive CGP analysis of the tissue sample using Positron Emission Tomography-Computed Tomography:Article Title: Pathological Complete Response after Conversion Surgery for Distal Cholangiocarcinoma with High Tumor Mutational Burden and Para-Aortic Lymph Node Metastasis: A Case Report Article Snippet: hich was within the normal range ( Fig. 3 ). The tumor resection was deemed ineligible, and GCD therapy was initiated as the first-line treatment. Comprehensive CGP analysis of the tissue sample using |